Articles published in Journal of AIDS & Clinical Research have been cited by esteemed scholars and scientists all around the world.
Journal of AIDS & Clinical Research has got h-index 29, which means every article in Journal of AIDS & Clinical Research has got 29 average citations.
Following are the list of articles that have cited the articles published in Journal of AIDS & Clinical Research.
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
Year wise published articles |
66 | 61 | 32 | 29 | 31 |
Year wise citations received |
484 | 590 | 666 | 563 | 560 |
| Journal total citations count | 5061 |
| Journal impact factor | 2.8 |
| Journal 5 years impact factor | 10.46 |
| Journal cite score | 9.49 |
| Journal h-index | 29 |
| Journal h-index since 2018 | 21 |
Chambers, L. A., Wilson, M. G., Rueda, S., Gogolishvili, D., Shi, M. Q., & Rourke, S. B. (2014). Evidence informing the intersection of HIV, aging and health: a scoping review. AIDS and behavior, 18(4), 661-675. |
|
Cabeza Brasa, M. D. C., Domingo, P., & Gurguí Ferrer, M. (2014). Implicación de los polimorfismos de las enzimas del metabolismo de las pirimidinas en los trastornos metabólicos y morfológicos asociados a la infección por VIH-1 y al TARGA. |
|
Ramadhani, H. O., Bartlett, J. A., Thielman, N. M., Pence, B. W., Kimani, S. M., Maro, V. P., ... & Lirhunde, E. S. (2016, January). The Effect of Switching to Second-Line Antiretroviral Therapy on the Risk of Opportunistic Infections Among Patients Infected With Human Immunodeficiency Virus in Northern Tanzania. In Open forum infectious diseases (Vol. 3, No. 1, p. ofw018). Oxford University Press. |
|
Gareta, D. P. (2014). Factors associated with antiretroviral resistance in human immunodeficiency virus patients on antiretroviral therapy in South Africa (Doctoral dissertation). |
|
Rohr, J. K., Ive, P., Horsburgh, C. R., Berhanu, R., Shearer, K., Maskew, M., ... & Fox, M. P. (2016). Marginal Structural Models to Assess Delays in Second-Line HIV Treatment Initiation in South Africa. PloS one, 11(8), e0161469. |
|
Scheibe, F. J., Waiswa, P., Kadobera, D., Müller, O., Ekström, A. M., Sarker, M., & Neuhann, H. F. (2013). Effective Coverage for Antiretroviral Therapy in a Ugandan District with a Decentralized Model of Care. PloS one, 8(7), e69433. |
|
Praveenya, P., Singh, B. K., Sathish Kumar, D., & Kalyan, P. (2012). Antibiotic Resistance Creating New Epoch. J Bacteriol Parasitol, 3(131), 2. |
|
Ramadhani, H. O., Bartlett, J. A., Thielman, N. M., Pence, B. W., Kimani, S. M., Maro, V. P., ... & Lirhunde, E. S. (2016). Open Forum Infectious Diseases Advance Access published January 28, 2016. |
|
Adapa, D., Sai, Y. R. K. M., Anand, S. Y., Mehaboobi, S., & Aramalla, E. R. (2011). A Brief Review on Immune Mediated Diseases. J Clin Cell Immunol S, 11, 2. |
|
Neogi, U. (2013). Translational genomics of HIV-1 subtype C in India: molecular phylogeny and drug resistance. Inst för medicin, Huddinge/Dept of Medicine, Huddinge. |
|
Naga Anusha, P. (2011). Antiretroviral Strategies for Treatment of HIV. J Antivir Antiretrovir, 1, 2. |
|
Rossouw, T. M., Nieuwoudt, M., Manasa, J., Malherbe, G., Lessells, R. J., Pillay, S., ... & Oliveira, T. (2017). HIV drug resistance levels in adults failing firstâ€Âline antiretroviral therapy in an urban and a rural setting in South Africa. HIV medicine, 18(2), 104-114. |
|
Steegen, K., Bronze, M., Papathanasopoulos, M. A., van Zyl, G., Goedhals, D., Variava, E., ... & Carmona, S. (2016). HIV-1 antiretroviral drug resistance patterns in patients failing NNRTI-based treatment: results from a national survey in South Africa. Journal of Antimicrobial Chemotherapy, dkw358. |
|
Pinoges, L., Schramm, B., Poulet, E., Balkan, S., Szumilin, E., Ferreyra, C., & Pujades-Rodríguez, M. (2015). Risk factors and mortality associated with resistance to first-line antiretroviral therapy: multicentric cross-sectional and longitudinal analyses. JAIDS Journal of Acquired Immune Deficiency Syndromes, 68(5), 527-535. |
|
Hima Bindu, A., & Naga Anusha, P. (2011). Adverse effects of highly active anti-retroviral therapy (HAART). J Antivir Antiretrovir, 3, 060-064. |
|
Rutstein, S. E., Hosseinipour, M. C., Kamwendo, D., Soko, A., Mkandawire, M., Biddle, A. K., ... & Gupta, S. (2015). Dried blood spots for viral load monitoring in Malawi: feasible and effective. PloS one, 10(4), e0124748. |
|
Hoffmann, C. J., Charalambous, S., Grant, A. D., Morris, L., Churchyard, G. J., & Chaisson, R. E. (2014). Durable HIV RNA resuppression after virologic failure while remaining on a firstâ€Âline regimen: a cohort study. Tropical medicine & international health, 19(2), 236-239. |
|
Neogi, U., Heylen, E., Shet, A., Chandy, S., Shamsunder, R., Sönnerborg, A., & Ekstrand, M. L. (2013). Long-term efficacy of first line antiretroviral therapy in Indian HIV-1 infected patients: a longitudinal cohort study. PLoS One, 8(1), e55421. |
|
Manasa, J., Lessells, R. J., Skingsley, A., Naidu, K. K., Newell, M. L., McGrath, N., & de Oliveira, T. (2013). High-levels of acquired drug resistance in adult patients failing first-line antiretroviral therapy in a rural HIV treatment programme in KwaZulu-Natal, South Africa. PLoS One, 8(8), e72152. |
|
Murphy, R. A., Sunpath, H., Castilla, C., Ebrahim, S., Court, R., Nguyen, H., ... & Nachega, J. B. (2012). Second-line antiretroviral therapy: long-term outcomes in South Africa. Journal of acquired immune deficiency syndromes (1999), 61(2), 158. |
|
Journal of AIDS & Clinical Research received 5061 citations as per Google Scholar report
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 